Anthem Biosciences Limited has informed the Exchange regarding a press release dated November 08, 2025, titled "Financial result for quarter and half year ended September 30, 2025".
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anthem Biosciences has informed the stock exchange about a press release dated November 8, 2025, covering its financial results for the quarter and half year ended September 30, 2025 (Q2 and H1 FY26). This filing is a regulatory intimation and does not itself contain the actual financial figures — it only confirms that the results have been published. Investors would need to refer to the detailed press release or the financial statements for revenue, profit, margins, and segment-wise performance. The timing suggests the company is complying with SEBI listing requirements to disclose quarterly results within the stipulated period.
This is a routine compliance filing and is unlikely to move the stock on its own. The actual market reaction will depend on the numbers in the detailed results — beats or misses on revenue and profit, margin trends, and any forward guidance will be the real drivers.